Otologic Pharmaceutics, Inc. is a company committed to developing treatments for acute hearing loss to reduce the development of permanent hearing disorders.
Year Founded: 2008
Year Partnered: 2014
Category: BioTech/Pharma
Fund: Angel Fund I, Accelerate, Oklahoma Seed Capital Fund